References

  1. Mirambo MM, Majigo M, Aboud S, Gross U, Mshana SE. Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review. BMC Res Notes.2015;8(1):716. PubMed | Google Scholar

  2. World Health Organization. Rubella vaccine; WHO Position Paper. Weekly Epidemiological Record. 2011; 29(86):301-316. PubMed | Google Scholar

  3. World Health Organization. Rubella factsheet. 2013a.. Google Scholar

  4. Miller E, Cradock-Watson J E, Pollock T M. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2(8302):781-784. PubMed | Google Scholar

  5. Clarke M, Schild G C, Boustred J, McGregor I A, Williams K. Epidemiological studies of rubella in a :tropical African community. Bull World Health Organ. 1980;58(6):391-395. PubMed | Google Scholar

  6. Goodson J L, Masresha B, Dosseh A, Byabamazima C, Nshimirimana D, Cochi S et al. Rubella epidemiology in Africa in the prevaccine era, 2002-2009. J Infec Diseases. 2011;204(1): 215-225. PubMed | Google Scholar

  7. Mirambo M M, Aboud S, Mushi MF, Seugendo M, Majigo M, Grob, G, Mshana SE. Serological evidence of acute rubella infection among under-fives in Mwanza: a threat to increasing rates of congenital rubella syndrome in Tanzania. Ital J Paed. 2016; 42(1):54. PubMed | Google Scholar

  8. Cutts F T, Robertson S E, Diaz-Ortega J L, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of disease from CRS. Bull World Health Organ. 1997;75(1): 55-68. PubMed | Google Scholar

  9. Lawn J E, Reef S, Baffoe-Bonnie B, Adadevoh S, Caul E O, Griffin G E. Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi, Ghana. American J Public Health.2000; 90(10):1555-1561. PubMed | Google Scholar

  10. Umeh C A, Onyi S C. Case based rubella surveillance in Abia State, South East Nigeria, 2007-2011. Peer J. 2014; 2(3): e580. PubMed | Google Scholar

  11. Mitiku K, Bedada T, Masresha B, Kegne W, Nafo-Traor'e F, Tesfaye N et al. The epidemiology of rubella disease in Ethiopia: data from the measles case-based surveillance system. Journal of Infectious Diseases. 2011;204(1):239-242. PubMed | Google Scholar

  12. Onakewhor J U, Chiwuzie J. Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria. Niger J Clin Pract. 2011;14(2):140-145. PubMed | Google Scholar

  13. Onyenekwe C C, Kehinde-Agbeyangi T A, Ofor U S, Arinola O G. Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria. West Afr J Med. 2000;19(1):23-26. PubMed | Google Scholar

  14. World Health Organization. Immunization, Vaccines and Biologicals. 2013b. Google Scholar

  15. World Health Organisation. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Bull World Health Org. 2011; 79 (4): 373-374. PubMed | Google Scholar

  16. MedCalc. Easy-to use statistical software. Accessed and Downloaded on. 12th August 216. Google Scholar

  17. Junaid S A, Akpan K J, Olabode A O. Sero-survey of rubella IgM antibodies among children in Jos, Nigeria. Virology Journal. 2011;19 (8): 244-248 18.Fatiregun A A, Fagbamigbe A F, Adebowale A S. Epidemiology of rubella disease in South- West Nigeria: trends and projection from measles case-based surveillance data. South Afr J Infectious Disease. 2014;29(2): 60-64. PubMed | Google Scholar

  18. Fatiregun A A, Fagbamigbe A F, Adebowale A S. Epidemiology of rubella disease in South- West Nigeria: trends and projection from measles case-based surveillance data. South Afr J Infectious Disease. 2014;29(2): 60- 64. PubMed | Google Scholar